Linezolid-associated adverse events and outcomes in the treatment of multidrug/rifampicin-resistant tuberculosis: A systematic review and meta-analysis of randomized controlled trials

This meta-analysis evaluated the safety and efficacy of linezolid-containing regimens for multidrug/rifampicin-resistant tuberculosis. Seven databases (January 2001–February 2026) were searched for randomized controlled trials comparing linezolid-containing regimens with standard of care (SOC). Pool...

Descrición completa

Detalles Bibliográficos

Principais autores:	Mita Restinia, Jheng-Yan Wu, Fajri Gafar, Wen-Hsuan Hou, Chung-Yi Li
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-05-01
Series:	Journal of Infection and Public Health
Assuntos:	Linezolid Adverse events Treatment outcomes Meta-analysis Multidrug/rifampicin-resistant tuberculosis
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S1876034126000845
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!